Copyright
©The Author(s) 2021.
World J Cardiol. Mar 26, 2021; 13(3): 55-67
Published online Mar 26, 2021. doi: 10.4330/wjc.v13.i3.55
Published online Mar 26, 2021. doi: 10.4330/wjc.v13.i3.55
Figure 1 Univariate analysis for clinical/laboratory/risk score parameters and interleukin-6.
Parametric survival regression, loglogistic distribution, wild-type P values. CRP: C-reactive protein; IL6: Interleukin-6; NTProBNP: N-terminal pro-brain natriuretic peptide; GFR: Glomerular filtration rate.
- Citation: Hein SJ, Knoll M, Aus dem Siepen F, Furkel J, Schoenland S, Hegenbart U, Katus HA, Kristen AV, Konstandin M. Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis. World J Cardiol 2021; 13(3): 55-67
- URL: https://www.wjgnet.com/1949-8462/full/v13/i3/55.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i3.55